Novo Nordisk
NVO
#110
Rank
NZ$325.57 B
Marketcap
NZ$73.86
Share price
0.96%
Change (1 day)
-14.99%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): NZ$4.61

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is NZ$7.09. In 2022 the company made an earnings per share (EPS) of NZ$3.90 an increase over its 2021 EPS that were of NZ$3.58.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$4.6118.25%
2022NZ$3.909.01%
2021NZ$3.5815.08%
2020NZ$3.1114.83%
2019NZ$2.71-1.68%
2018NZ$2.754.96%
2017NZ$2.6231.08%
2016NZ$2.00-10.33%
2015NZ$2.2313.91%
2014NZ$1.964.03%
2013NZ$1.88-28.81%
2012NZ$2.65108.9%
2011NZ$1.2725.59%
2010NZ$1.0135.01%
2009NZ$0.75-9.17%
2008NZ$0.8261.35%
2007NZ$0.5128.96%
2006NZ$0.4025.63%
2005NZ$0.314.17%
2004NZ$0.3013.55%
2003NZ$0.2736.87%
2002NZ$0.19-6.99%
2001NZ$0.2121.56%
2000NZ$0.1749.45%
1999NZ$0.123.78%
1998NZ$0.1112.15%
1997NZ$0.0988324.74%
1996NZ$0.07923

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.28-82.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.52 682.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.56-49.81%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$8.12 14.55%๐Ÿ‡บ๐Ÿ‡ธ USA